Systematic (IUPAC) name | |
---|---|
(RS)-5-allyl-5-(2-hydroxypropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
|
|
Identifiers | |
CAS Registry Number | 2537-29-3 |
ATC code | N05CA22 |
PubChem | CID: 17336 |
ChemSpider | 16406 |
Synonyms | Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid |
Chemical data | |
Formula | C10H14N2O4 |
Molecular mass | 226.229 g/mol |
|
|
|
|
(what is this?) (verify) |
Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956. It has anti-anxiety properties and in contrast to most barbiturates almost without hypnotic action.[1]
It was also used in the treatment of migraine headaches in a similar manner to butalbital.[2]
References
- ^ Zajdel, P.; Kulig, K.; Zejc, A. (2008). Zejc, A.; Gorczyca, M., eds. Chemia leków, podręcznik dla studentów farmacji i farmaceutów (in Polish). Warszawa, Poland. ISBN 978-83-200-3652-7.
- ^ Sulman, F. G.; Pfeifer, Y.; Tal, E. (1976). "Migraine therapy by enzyme induction with proxibarbital". Therapie der Gegenwart (in German) 115 (12): 2088–2103. PMID 14412.
|